Jonathan S. Wall
20Patents
6h-index
13Co-inventors
66Inventor score
Filing activity: Apr 30, 1999 → May 9, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6423270B1 | Flow cytometric characterization of amyloid fibrils | Physics | 25 | Expired |
| US7928203B2 | Chimeric, humanized, or human antibody 2A4 | Emerging Cross-Sectional Technologies | 20 | Active |
| US6245572A | Flow cytometric characterization of amyloid fibrils | Physics | 10 | Expired |
| US8105594B2 | Methods for amyloid removal using anti-amyloid antibodies | Human Necessities | 9 | Active |
| US10046050B2 | Targeting immunotherapy for amyloidosis | Physics | 8 | Active |
| US8808666B2 | Peptides that specifically target amyloid deposits | Physics | 6 | Active |
| US10213506B2 | Targeting immunotherapy for amyloidosis | Physics | 6 | Active |
| US8791243B2 | Treatment and prophylaxis of amyloidosis | Emerging Cross-Sectional Technologies | 6 | Active |
| US9683017B2 | Inhibitory peptides of viral infection | Chemistry; Metallurgy | 6 | Active |
| US10308685B2 | Inhibitory peptides of viral infection | Chemistry; Metallurgy | 6 | Active |
| USRE47838E1 | Inhibitory peptides of viral infection | General | 5 | Active |
| US12030934B2 | Modified immunoglobulins for targeting amyloid deposits | Chemistry; Metallurgy | 3 | Active |
| US10646568B2 | Targeting immunotherapy for amyloidosis | Physics | 2 | Active |
| US12157765B2 | Modified immunoglobulins for targeting amyloid deposits | Chemistry; Metallurgy | 1 | Active |
| US12139529B2 | Antibody-peptide fusion proteins for treating amyloid disorders | Chemistry; Metallurgy | 1 | Active |
| US12264195B2 | Modified immunoglobulins for targeting amyloid deposits | Chemistry; Metallurgy | 0 | Active |
| US11293925B2 | Identifying amyloidogenic proteins and amyloidogenic risk | Physics | 0 | Active |
| US7485616B2 | Methods of investigating, diagnosing, and treating amyloidosis | Human Necessities | 0 | Expired |
| US8636981B2 | Detection of amyloid deposits using anti-amyloid antibodies | Emerging Cross-Sectional Technologies | 0 | Active |
| US12161692B2 | SAP FC fusion proteins and methods of use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.